Clinical Trials Directory

Trials / Completed

CompletedNCT01518699

Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers

A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Effect of Ha44 Gel on the ECG in Healthy Adult Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Dr. Reddy's Laboratories Limited · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers.

Detailed description

This study was a randomized, double-blind, placebo- and active-controlled, crossover study that evaluated the potential of Abametapir to prolong cardiac repolarization in healthy adult subjects (total of 57 subjects).

Conditions

Interventions

TypeNameDescription
DRUGHa44Abametapir Lotion 0.74%
DRUGHa44 PlaceboHa44 Vehicle Gel without Abametapir
DRUGMoxifloxacin PlaceboMoxifloxacin Placebo
DRUGMoxifloxacinMoxifloxacin 400mg

Timeline

Start date
2012-01-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2012-01-26
Last updated
2021-07-09
Results posted
2021-07-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01518699. Inclusion in this directory is not an endorsement.